Schizophrenia 4

Common Name(s)

Schizophrenia 4

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Schizophrenia 4" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Schizophrenia 4" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Schizophrenia 4" returned 26 free, full-text research articles on human participants. First 3 results:

IL-4, TGF-, NF-B and MPO levels in Patients with Treatment Resistant Schizophrenia.
 

Author(s): Şükrü Kartalcı, Lale Gönenir Erbay, Esra Porgalı Zayman, Önder Otlu, Aysun Bay Karabulut, Gülşen Kartalcı

Journal: Turk Psikiyatri Derg. 2016 ;27(3):170-175.

 

Schizophrenia is a chronic psychotic disorder in which genetics and environmental factors such as infection and the corresponding immune response play a role in the etiopathogenesis. The aim of this study was to compare some immune factors such as nuclear factor-B (NF-B) activation, ...

Last Updated: 6 Oct 2016

Go To URL
Schizophrenia risk from complex variation of complement component 4.
 

Author(s): Aswin Sekar, Allison R Bialas, Heather de Rivera, Avery Davis, Timothy R Hammond, Nolan Kamitaki, Katherine Tooley, Jessy Presumey, Matthew Baum, Vanessa Van Doren, Giulio Genovese, Samuel A Rose, Robert E Handsaker, , Mark J Daly, Michael C Carroll, Beth Stevens, Steven A McCarroll

Journal: Nature. 2016 Feb;530(7589):177-83.

 

Schizophrenia is a heritable brain illness with unknown pathogenic mechanisms. Schizophrenia's strongest genetic association at a population level involves variation in the major histocompatibility complex (MHC) locus, but the genes and molecular mechanisms accounting for this have ...

Last Updated: 11 Feb 2016

Go To URL
Preliminary investigation of 6,7-dihydropyrazolo[1,5-a]pyrazin-4-one derivatives as a novel series of mGlu5 receptor positive allosteric modulators with efficacy in preclinical models of schizophrenia.
 

Author(s): Susana Conde-Ceide, Jesús Alcázar, Sergio A Alonso de Diego, Silvia López, María Luz Martín-Martín, Carlos M Martínez-Viturro, Miguel-Angel Pena, Han Min Tong, Hilde Lavreysen, Claire Mackie, Thomas M Bridges, J Scott Daniels, Colleen M Niswender, Carrie K Jones, Gregor J Macdonald, Thomas Steckler, P Jeffrey Conn, Shaun R Stauffer, Craig W Lindsley, José Manuel Bartolomé-Nebreda

Journal: Bioorg. Med. Chem. Lett.. 2016 Jan;26(2):429-34.

 

As part of our efforts to identify a suitable back-up compound to our recently disclosed mGlu5 positive allosteric modulator (PAM) clinical candidate VU0490551/JNJ-46778212, this letter details the investigation and challenges of a novel series of 6,7-dihydropyrazolo[1,5-a]pyrazin-4-one ...

Last Updated: 8 Jan 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Schizophrenia 4" returned 0 free, full-text review articles on human participants.

 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Trial of DMXB-A in Schizophrenia
 

Status: Recruiting

Condition Summary: Schizophrenia

 

Last Updated: 4 Dec 2015

Go to URL

Last Updated: 10 Apr 2017

Go to URL

Last Updated: 25 Apr 2016

Go to URL